We are IntechOpen, the world’s leading publisher of Open Access books Built by scientists, for scientists

integrative, basic and clinical approaches based on recent developments in the field of gastroenterology. The most important advances in the pathophysiology and treatment of gastrointestinal disorders are discussed including; gastroesophageal reflux disease (GERD), peptic ulcer disease, irritable bowel disease (IBD), NSAIDs-induced gastroenteropathy and pancreatitis

[1]  T. Iwata,et al.  Predictors of Hyperperfusion Syndrome Before and Immediately After Carotid Artery Stenting in Single-Photon Emission Computed Tomography and Transcranial Color-Coded Real-Time Sonography Studies , 2011, Neurosurgery.

[2]  J. Shalhoub,et al.  Hypertension and the post-carotid endarterectomy cerebral hyperperfusion syndrome. , 2011, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

[3]  M. Eskandari,et al.  Timing of carotid surgery after acute stroke , 2010, Expert review of cardiovascular therapy.

[4]  J. S. Kim,et al.  Outcome Evaluation of Carotid Stenting in High-Risk Patients with Symptomatic Carotid near Occlusion , 2010, Interventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences.

[5]  F. Setacci,et al.  Carotid artery stenting in recently symptomatic patients: a single center experience. , 2010, Annals of vascular surgery.

[6]  C. Gandolfo,et al.  Transient Encephalopathy from Angiographic Contrast: A Rare Complication in Neurointerventional Procedures , 2010, CardioVascular and Interventional Radiology.

[7]  O. Jansen,et al.  Complication rate in unprotected carotid artery stenting with closed-cell stents , 2010, Neuroradiology.

[8]  S. A. Meyer,et al.  Outcomes of Carotid Artery Stenting in High‐Risk Patients With Carotid Artery Stenosis: A Single Neurovascular Center Retrospective Review of 101 Consecutive Patients , 2010, Neurosurgery.

[9]  Gelin Xu,et al.  Posterior circulation hyperperfusion syndrome after bilateral vertebral artery intracranial stenting. , 2009, Annals of vascular surgery.

[10]  W. Kuan,et al.  Change in Cerebral Perfusion after Carotid Angioplasty with Stenting Is Related to Cerebral Vasoreactivity: A Study Using Dynamic Susceptibility-Weighted Contrast-Enhanced MR Imaging and Functional MR Imaging with a Breath-Holding Paradigm , 2009, American Journal of Neuroradiology.

[11]  Tsong-Hai Lee,et al.  Prediction of Cerebral Hyperperfusion Syndrome After Carotid Stenting: A Cerebral Perfusion Computed Tomography Study , 2009, Journal of computer assisted tomography.

[12]  J. Kira,et al.  Near-infrared spectroscopy in carotid artery stenting predicts cerebral hyperperfusion syndrome , 2009, Neurology.

[13]  G. Arsos,et al.  Cerebral Hyperperfusion After Carotid Stenting: A Transcranial Doppler and SPECT Study , 2009, Vascular and endovascular surgery.

[14]  K. Moulakakis,et al.  Hyperperfusion syndrome after carotid revascularization. , 2009, Journal of vascular surgery.

[15]  R. J. Valentine,et al.  Intracranial hemorrhage after carotid endarterectomy and carotid stenting in the United States in 2005. , 2009, Journal of vascular surgery.

[16]  P. Meyers,et al.  Radiographic Evidence of Cerebral Hyperperfusion and Reversal Following Angioplasty and Stenting of Intracranial Carotid and Middle Cerebral Artery Stenosis: Case report and review of the literature , 2009, Journal of neuroimaging : official journal of the American Society of Neuroimaging.

[17]  C. Phatouros,et al.  Cerebral hyperperfusion syndrome post‐carotid artery stenting , 2009, Journal of medical imaging and radiation oncology.

[18]  M. Maeda,et al.  Periprocedural hemodynamic instability with carotid angioplasty and stenting. , 2008, Surgical neurology.

[19]  C. Karkos,et al.  Cerebral perfusion patterns in patients with extracranial carotid atherosclerosis and the impact of carotid stenting. A review. , 2008, Journal of Cardiovascular Surgery.

[20]  Sung-Chun Tang,et al.  Dynamic cerebral autoregulation in carotid stenosis before and after carotid stenting. , 2008, Journal of vascular surgery.

[21]  T. Iwai,et al.  Urgent stenting for patients with acute stroke due to atherosclerotic occlusive lesions of the cervical internal carotid artery. , 2008, Neurologia medico-chirurgica.

[22]  K. Ogasawara,et al.  Intracranial hemorrhage associated with cerebral hyperperfusion syndrome following carotid endarterectomy and carotid artery stenting: retrospective review of 4494 patients. , 2007, Journal of neurosurgery.

[23]  P. Lin,et al.  Factors associated with hypotension and bradycardia after carotid angioplasty and stenting. , 2007, Journal of vascular surgery.

[24]  C. Derdeyn,et al.  Carotid angioplasty and stenting in the elderly , 2007, Neuroradiology.

[25]  Takashi Inoue,et al.  Concentration of malondialdehyde-modified low-density lipoprotein in the jugular bulb during carotid endarterectomy correlates with development of postoperative cognitive impairment. , 2007, Neurosurgery.

[26]  M. Wintermark,et al.  Subclinical embolization after carotid artery stenting: new lesions on diffusion-weighted magnetic resonance imaging occur postprocedure. , 2007, Journal of vascular surgery.

[27]  C. Bajzer,et al.  Intensive treatment of hypertension decreases the risk of hyperperfusion and intracerebral hemorrhage following carotid artery stenting , 2007, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[28]  V. Adhiyaman,et al.  Cerebral hyperperfusion syndrome following carotid endarterectomy. , 2007, QJM : monthly journal of the Association of Physicians.

[29]  À. Rovira,et al.  [Extravasation of contrast medium after carotid stent with brain infarction symptoms]. , 2007, Neurología.

[30]  H. Kuriyama,et al.  Complete regression of xenografted human carcinomas by a paclitaxel-carboxymethyl dextran conjugate (AZ10992). , 2007, Journal of controlled release : official journal of the Controlled Release Society.

[31]  A. Dimitriadis,et al.  The impact of carotid stenting on the hemodynamic parameters and cerebrovascular reactivity of the ipsilateral middle cerebral artery. , 2006, Journal of vascular surgery.

[32]  R. Higashida,et al.  Hyperperfusion syndrome after intracranial angioplasty and stent placement. , 2006, Stroke.

[33]  M. Knauth,et al.  Hyperacute intracerebral hemorrhage complicating carotid stenting should be distinguished from hyperperfusion syndrome. , 2006, AJNR. American journal of neuroradiology.

[34]  M. Sitzer,et al.  Diffusion-weighted MR imaging lesions after filter-protected stenting of high-grade symptomatic carotid artery stenoses. , 2006, AJNR. American journal of neuroradiology.

[35]  W. Couet,et al.  Enhanced Oral Paclitaxel Bioavailability After Administration of Paclitaxel-Loaded Lipid Nanocapsules , 2006, Pharmaceutical Research.

[36]  R. Govindan,et al.  Novel formulations of taxanes: a review. Old wine in a new bottle? , 2006, Annals of oncology : official journal of the European Society for Medical Oncology.

[37]  Ick Chan Kwon,et al.  Hydrophobically modified glycol chitosan nanoparticles as carriers for paclitaxel. , 2006, Journal of controlled release : official journal of the Controlled Release Society.

[38]  E. Beghi,et al.  Hemodynamic instability after extracranial carotid stenting , 2006, Acta Neurochirurgica.

[39]  G. Pilz,et al.  Reversible cerebral hyperperfusion syndrome after stenting of the carotid artery—Two case reports , 2006, Clinical Research in Cardiology.

[40]  P. Hofman,et al.  Cerebral hyperperfusion syndrome , 2005, The Lancet Neurology.

[41]  Hesson Chung,et al.  Bioadhesive Drug Delivery System Using Glyceryl Monooleate for the Intravesical Administration of Paclitaxel , 2005, Chemotherapy.

[42]  M. Caffrey,et al.  Controlling release from the lipidic cubic phase. Amino acids, peptides, proteins and nucleic acids. , 2005, Journal of controlled release : official journal of the Controlled Release Society.

[43]  R. Dayal,et al.  Carotid angioplasty and stent-induced bradycardia and hypotension: Impact of prophylactic atropine administration and prior carotid endarterectomy. , 2005, Journal of vascular surgery.

[44]  Masaki Watanabe,et al.  Emergency carotid artery stent placement in patients with acute ischemic stroke. , 2005, AJNR. American journal of neuroradiology.

[45]  I. Henry,et al.  Bilateral carotid angioplasty and stenting , 2005, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[46]  Alastair J. Martin,et al.  Magnetic Resonance Perfusion Tracks 133Xe Cerebral Blood Flow Changes After Carotid Stenting , 2005, Stroke.

[47]  B. Boyd,et al.  Influence of the intermediate digestion phases of common formulation lipids on the absorption of a poorly water-soluble drug. , 2005, Journal of pharmaceutical sciences.

[48]  I. Kwon,et al.  Stable paclitaxel formulations in oily contrast medium. , 2005, Journal of controlled release : official journal of the Controlled Release Society.

[49]  G. Craciun,et al.  Controlling release from the lipidic cubic phase by selective alkylation. , 2005, Journal of controlled release : official journal of the Controlled Release Society.

[50]  W. Moon,et al.  Prospective analysis of cerebral infarction after carotid endarterectomy and carotid artery stent placement by using diffusion-weighted imaging. , 2005, AJNR. American journal of neuroradiology.

[51]  Reto Meuli,et al.  Postcarotid Endarterectomy Hyperperfusion or Reperfusion Syndrome , 2004 .

[52]  Takashi Inoue,et al.  Pretreatment with the Free Radical Scavenger Edaravone Prevents Cerebral Hyperperfusion after Carotid Endarterectomy , 2004, Neurosurgery.

[53]  K. Aizawa,et al.  Inhibitory effect of a bitter melon extract on the P‐glycoprotein activity in intestinal Caco‐2 cells , 2004, British journal of pharmacology.

[54]  S. Yoshimura,et al.  Factors predictive of cerebral hyperperfusion after carotid angioplasty and stent placement. , 2004, AJNR. American journal of neuroradiology.

[55]  Tooru Inoue,et al.  Diagnostic Impact of Transcranial Color-Coded Real-Time Sonography With Echo Contrast Agents for Hyperperfusion Syndrome After Carotid Endarterectomy , 2004, Stroke.

[56]  J. Schellens,et al.  Efficacy of novel P-glycoprotein inhibitors to increase the oral uptake of paclitaxel in mice , 2004, Investigational New Drugs.

[57]  R. Peto,et al.  Prevention of disabling and fatal strokes by successful carotid endarterectomy in patients without recent neurological symptoms: randomised controlled trial , 2004, The Lancet.

[58]  Deepak L. Bhatt,et al.  Intracranial hemorrhage and hyperperfusion syndrome following carotid artery stenting: risk factors, prevention, and treatment. , 2004, Journal of the American College of Cardiology.

[59]  Hoo-Kyun Choi,et al.  Enhanced bioavailability of paclitaxel after oral coadministration with flavone in rats. , 2004, International journal of pharmaceutics.

[60]  J. Karemaker,et al.  Baroreflex failure: a neglected type of secondary hypertension. , 2004, The Netherlands journal of medicine.

[61]  M. Cho,et al.  Novel Oral Formulation of Paclitaxel Inhibits Neointimal Hyperplasia in a Rat Carotid Artery Injury Model , 2004, Circulation.

[62]  Youn-Chul Kim,et al.  Enhanced paclitaxel bioavailability after oral administration of paclitaxel or prodrug to rats pretreated with quercetin. , 2004, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[63]  S. Benita,et al.  Enhanced Oral Absorption of Paclitaxel in a Novel Self-Microemulsifying Drug Delivery System with or Without Concomitant Use of P-Glycoprotein Inhibitors , 2004, Pharmaceutical Research.

[64]  K. Garber.  Improved Paclitaxel formulation hints at new chemotherapy approach. , 2004, Journal of the National Cancer Institute.

[65]  P. Gao,et al.  Development of a supersaturable SEDDS (S-SEDDS) formulation of paclitaxel with improved oral bioavailability. , 2003, Journal of pharmaceutical sciences.

[66]  G. Sutherland,et al.  Hyperperfusion Syndrome: Toward a Stricter Definition , 2003, Neurosurgery.

[67]  Takashi Inoue,et al.  Prediction and monitoring of cerebral hyperperfusion after carotid endarterectomy by using single-photon emission computerized tomography scanning. , 2003, Journal of neurosurgery.

[68]  S. Aalto,et al.  Effects of Sevoflurane, Propofol, and Adjunct Nitrous Oxide on Regional Cerebral Blood Flow, Oxygen Consumption, and Blood Volume in Humans , 2003, Anesthesiology.

[69]  Takashi Inoue,et al.  Transcranial Regional Cerebral Oxygen Saturation Monitoring during Carotid Endarterectomy as a Predictor of Postoperative Hyperperfusion , 2003, Neurosurgery.

[70]  A. Naylor,et al.  Seizures after carotid endarterectomy: hyperperfusion, dysautoregulation or hypertensive encephalopathy? , 2003, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

[71]  Eiji Kohmura,et al.  Prediction of Hyperperfusion After Carotid Endarterectomy by Brain SPECT Analysis With Semiquantitative Statistical Mapping Method , 2003, Stroke.

[72]  Guterman,et al.  Staged stent-assisted angioplasty for symptomatic intracranial vertebrobasilar artery stenosis. , 2002, Journal of neurosurgery.

[73]  J. Suarez,et al.  Intracerebral Hemorrhages Associated With Neurointerventional Procedures Using a Combination of Antithrombotic Agents Including Abciximab , 2002, Stroke.

[74]  Patrick Soon-Shiong,et al.  Phase I and pharmacokinetic study of ABI-007, a Cremophor-free, protein-stabilized, nanoparticle formulation of paclitaxel. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

[75]  D. Aggarwal,et al.  Paclitaxel and its formulations. , 2002, International journal of pharmaceutics.

[76]  R. Beyar,et al.  Ipsilateral Intracerebral Hemorrhage Following Carotid Stent-Assisted Angioplasty: A Manifestation of Hyperperfusion Syndrome , 2002, Angiology.

[77]  I. Kwon,et al.  Self-assembled “nanocubicle” as a carrier for peroral insulin delivery , 2002, Diabetologia.

[78]  R. Schwartz.  HYPERPERFUSION ENCEPHALOPATHIES: HYPERTENSIVE ENCEPHALOPATHY AND RELATED CONDITIONS , 2002, The neurologist.

[79]  M. Leon,et al.  Subarachnoidal hemorrhage following carotid stenting with the distal‐balloon protection , 2001, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[80]  E. Wijdicks,et al.  Mechanisms of intracerebral hemorrhage after carotid endarterectomy. , 2001, Journal of Neurosurgery.

[81]  G. Albers,et al.  Hyperperfusion syndrome with hemorrhage after angioplasty for middle cerebral artery stenosis. , 2001, AJNR. American journal of neuroradiology.

[82]  R. Keunen,et al.  An observational study of pre-operative transcranial Doppler examinations to predict cerebral hyperperfusion following carotid endarterectomies , 2001, Neurological research.

[83]  N. Tamaki,et al.  Cerebral Vasoreactivity and Internal Carotid Artery Flow Help to Identify Patients at Risk for Hyperperfusion After Carotid Endarterectomy , 2001, Stroke.

[84]  S. Nagahiro,et al.  Hyperperfusion phenomenon after percutaneous transluminal angioplasty for atherosclerotic stenosis of the intracranial vertebral artery. Case report. , 2001, Journal of neurosurgery.

[85]  I. Kwon,et al.  Oil components modulate physical characteristics and function of the natural oil emulsions as drug or gene delivery system. , 2001, Journal of controlled release : official journal of the Controlled Release Society.

[86]  G. Dangas,et al.  Transient contrast encephalopathy after carotid artery stenting. , 2001, Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists.

[87]  J. Schellens,et al.  Modulation of oral bioavailability of anticancer drugs: from mouse to man. , 2000, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[88]  M. Hudon,et al.  Intracranial hemorrhage after stenting and angioplasty of extracranial carotid stenosis. , 2000, AJNR. American journal of neuroradiology.

[89]  J. Rathman,et al.  Phase behavior of a monoacylglycerol: (myverol 18-99K)/water system. , 2000, Chemistry and physics of lipids.

[90]  M. Strotzer,et al.  Leptomeningeal enhancement and extravasation of contrast medium into the CSF space? , 2000, Stroke.

[91]  Yan Wang,et al.  Epileptic Seizures Attributed to Cerebral Hyperperfusion after Percutaneous Transluminal Angioplasty and Stenting of the Internal Carotid Artery , 2000, Cerebrovascular Diseases.

[92]  A M Malek,et al.  Cerebral hyperperfusion syndrome after percutaneous transluminal stenting of the craniocervical arteries. , 2000, Neurosurgery.

[93]  M. Caffrey,et al.  The phase diagram of the monoolein/water system: metastability and equilibrium aspects. , 2000, Biomaterials.

[94]  D. Quintanar-Guerrero,et al.  Monoolein: A Review of the Pharmaceutical Applications , 2000, Drug development and industrial pharmacy.

[95]  T. Mima,et al.  Intraventricular Hemorrhage after Carotid Stenting , 1999, Journal of endovascular surgery : the official journal of the International Society for Endovascular Surgery.

[96]  M. Brown,et al.  Fatal cerebral reperfusion hemorrhage after carotid stenting. , 1999, Stroke.

[97]  J. Schellens,et al.  Coadministration of oral cyclosporin A enables oral therapy with paclitaxel. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

[98]  A. Luft,et al.  Frequency and determinants of postprocedural hemodynamic instability after carotid angioplasty and stenting. , 1999, Stroke.

[99]  F. Moll,et al.  Transcranial Doppler monitoring during carotid endarterectomy helps to identify patients at risk of postoperative hyperperfusion. , 1999, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

[100]  C. J. Lee,et al.  Development of nonionic surfactant/phospholipid o/w emulsion as a paclitaxel delivery system. , 1999, Journal of controlled release : official journal of the Controlled Release Society.

[101]  R. Beach,et al.  Contrast agent neurotoxicity presenting as subarachnoid hemorrhage , 1999, Neurology.

[102]  N. Weissman,et al.  Acute hemodynamic changes during carotid artery stenting. , 1998, The American journal of cardiology.

[103]  Der,et al.  Enhanced oral absorption and decreased elimination of paclitaxel in mice cotreated with cyclosporin A. , 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.

[104]  L. Nielsen,et al.  Bioadhesive drug delivery systems: I. Characterisation of mucoadhesive properties of systems based on glyceryl mono-oleate and glyceryl monolinoleate , 1998 .

[105]  K. Hosoda,et al.  Influence of degree of carotid artery stenosis and collateral pathways and effect of carotid endarterectomy on cerebral vasoreactivity. , 1998, Neurosurgery.

[106]  H. Lanfermann,et al.  Transient bilateral cortical blindness after coronary angiography , 1998, The Lancet.

[107]  L. Monsein,et al.  Subarachnoid contrast enhancement after spinal angiography mimicking diffuse subarachnoid hemorrhage. , 1998, AJR. American journal of roentgenology.

[108]  W L Hunter,et al.  Solid-state characterization of paclitaxel. , 1997, Journal of pharmaceutical sciences.

[109]  J. Beijnen,et al.  Enhanced oral bioavailability of paclitaxel in mice treated with the P-glycoprotein blocker SDZ PSC 833. , 1997, British Journal of Cancer.

[110]  J. Beijnen,et al.  Limited oral bioavailability and active epithelial excretion of paclitaxel (Taxol) caused by P-glycoprotein in the intestine. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[111]  G. Mead,et al.  Cerebral oximetry: a useful monitor during carotid artery surgery , 1996, Anaesthesia.

[112]  Martin Caffrey,et al.  The Temperature-Composition Phase Diagram and Mesophase Structure Characterization of the Monoolein/Water System , 1996 .

[113]  J. Beijnen,et al.  Nonlinear pharmacokinetics of paclitaxel in mice results from the pharmaceutical vehicle Cremophor EL. , 1996, Cancer research.

[114]  A. Penn,et al.  Imaging studies of cerebral hyperperfusion after carotid endarterectomy. Case report. , 1995, Journal of neurosurgery.

[115]  M. Egorin,et al.  Paclitaxel pharmacokinetics and pharmacodynamics. , 1995, Seminars in oncology.

[116]  F. Moll,et al.  Prediction of intracerebral haemorrhage after carotid endarterectomy by clinical criteria and intraoperative transcranial Doppler monitoring. , 1994, European journal of vascular surgery.

[117]  F. Moll,et al.  Prediction of intracerebral haemorrhage after carotid endarterectomy by clinical criteria and intraoperative transcranial Doppler monitoring: results of 233 operations. , 1994, European journal of vascular surgery.

[118]  M. Daniels,et al.  Precipitation of paclitaxel during infusion by pump. , 1993, American journal of hospital pharmacy.

[119]  J. Reed,et al.  The cerebral hyperperfusion syndrome: diagnostic value of ocular pneumoplethysmography. , 1993, Journal of vascular surgery.

[120]  D E Sakas,et al.  The role of neuroeffector mechanisms in cerebral hyperperfusion syndromes. , 1991, Journal of neurosurgery.

[121]  B. Leyland-Jones,et al.  Hypersensitivity reactions from taxol. , 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[122]  W. Moore,et al.  Post-carotid endarterectomy hypertension: association with elevated cranial norepinephrine. , 1989, Journal of vascular surgery.

[123]  T. Sundt,et al.  Intracerebral hemorrhage after carotid endarterectomy. , 1988, Journal of neurosurgery.

[124]  R. Busuttil,et al.  Incidence and mechanism of post-carotid endarterectomy hypertension. , 1987, Archives of surgery.

[125]  T. Sundt,et al.  Cerebral hyperperfusion syndrome: a cause of neurologic dysfunction after carotid endarterectomy. , 1987, Journal of vascular surgery.

[126]  M. Bernstein,et al.  Cerebral hyperperfusion after carotid endarterectomy: a cause of cerebral hemorrhage. , 1984, Neurosurgery.

[127]  T. Riles,et al.  Early complications of carotid surgery. , 1984, International surgery.

[128]  J. L. Skudlarick,et al.  Systolic Hypertension and Complications of Carotid Endarterectomy , 1982, Southern medical journal.

[129]  W. Fry,et al.  Hypotension and hypertension as consequences of baroreceptor dysfunction following carotid endarterectomy. , 1979, Surgery.

[130]  Chiung‐Jen Wu,et al.  Transient contrast encephalopathy after carotid artery stenting mimicking diffuse subarachnoid hemorrhage: A case report , 2009, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[131]  F. Mendelsohn,et al.  Hyperperfusion syndrome following carotid artery stenting: the largest single-operator series to date. , 2009, The Journal of invasive cardiology.

[132]  A. Casasco,et al.  [A case of temporary nonthrombotic hemiplegia and aphasia due to neurotoxicity from angiographic contrast material?]. , 2009, Radiología.

[133]  B. Shin,et al.  Enhanced absorption and tissue distribution of paclitaxel following oral administration of DHP 107, a novel mucoadhesive lipid dosage form , 2009, Cancer Chemotherapy and Pharmacology.

[134]  A. D. Ammar,et al.  The Incidence of Ischemic Stroke versus Intracerebral Hemorrhage after Carotid Endarterectomy: A Review of 2452 Cases , 2005, Annals of vascular surgery.

[135]  Takashi Inoue,et al.  Postoperative cerebral hyperperfusion associated with impaired cognitive function in patients undergoing carotid endarterectomy. , 2005, Journal of neurosurgery.

[136]  Jun-shik Choi,et al.  The effect of verapamil on the pharmacokinetics of paclitaxel in rats. , 2005, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[137]  Sung-Joo Hwang,et al.  Enhanced Oral Bioavailability of Paclitaxel by Coadministration of the P-Glycoprotein Inhibitor KR30031 , 2004, Pharmaceutical Research.

[138]  Jeong Hun Lee,et al.  Preparation and Characterization of Solvent Induced Dihydrated, Anhydrous, and Amorphous Paclitaxel , 2001 .

[139]  P. J. Hoopes,et al.  Visualization of intravenously administered contrast material in the CSF on fluid-attenuated inversion-recovery MR images: an in vitro and animal-model investigation. , 2000, AJNR. American journal of neuroradiology.

[140]  J. Broderick,et al.  A Case of Cerebral Hemorrhage Early After Carotid Stenting , 2000 .

[141]  T. Itakura,et al.  Haemorrhagic Complication Following Percutaneous Transluminal Angioplasty for Carotid Stenosis , 2000, Acta Neurochirurgica.

[142]  W. Yuh,et al.  Severe occlusive carotid artery disease: hemodynamic assessment by MR perfusion imaging in symptomatic patients. , 1999, AJNR. American journal of neuroradiology.

[143]  R. Green,et al.  Intracerebral hemorrhage after carotid endarterectomy: incidence, contribution to neurologic morbidity, and predictive factors. , 1999, Journal of vascular surgery.

[144]  J. Pniewski,et al.  Comparison of near-infrared spectroscopy and somatosensory evoked potentials for the detection of cerebral ischemia during carotid endarterectomy. , 1999, Stroke.

[145]  W. White,et al.  Intracerebral hemorrhage after carotid endarterectomy associated with ipsilateral fibrinoid necrosis: a consequence of the hyperperfusion syndrome? , 1996, Journal of vascular surgery.

[146]  G. Bonadonna,et al.  Nonlinear pharmacokinetics and metabolism of paclitaxel and its pharmacokinetic/pharmacodynamic relationships in humans. , 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[147]  B R Goldspiel,et al.  Paclitaxel (Taxol) , 1994, Pharmacotherapy.

[148]  R. A. Solomon,et al.  Incidence and etiology of intracerebral hemorrhage following carotid endarterectomy. , 1986, Journal of neurosurgery.

[149]  R. Takolander,et al.  Intracerebral haemorrhage after internal carotid endarterectomy. , 1983, Acta chirurgica Scandinavica.